Published in

American Society of Clinical Oncology, Journal of Clinical Oncology, 15_suppl(36), p. 9097-9097, 2018

DOI: 10.1200/jco.2018.36.15_suppl.9097

Links

Tools

Export citation

Search in Google Scholar

Randomized phase II trial evaluating treatment with EGFR-TKI versus EGFR-TKI associated with anti-estrogen in women with non-squamous advanced stage NSCLC: IFCT-1003 LADIE trial

Journal article published in 2018 by Julien Mazieres, Fabrice Barlesi, Isabelle Rouquette, Benjamin Besse, Isabelle Monnet, Clarisse Audigier-Valette, Anne Claire Toffart, Patrick-Aldo Renault, Severine Moreau Fraboulet, Severine Moreau Fraboulet, Sandrine Hiret, Bertrand Mennecier, Didier Debieuvre, Virginie Westeel, Philippe Masson and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO